Cannabis Regulation and Reinvestment Act

Full Title:
Cannabis Administration and Opportunity Act

Summary#

This bill would remove cannabis from the federal list of controlled substances and set up a new federal system to tax, regulate, and study cannabis. It creates federal agencies, permit rules, product standards, and large grant programs aimed at communities harmed by past cannabis enforcement. It also requires courts and agencies to clear or vacate many past federal cannabis convictions and bars immigration or federal benefit penalties solely for cannabis-related events.

Key changes:

  • Decriminalizes and deschedules cannabis under the Controlled Substances Act and makes that change retroactive for many past federal cases.
  • Moves cannabis oversight from the Drug Enforcement Administration to the Departments of Health and Human Services and Treasury, and renames the Tax and Trade Bureau to include cannabis.
  • Creates a federal tax and Opportunity Trust Fund for cannabis products and directs substantial appropriations into research, public health, and community reinvestment programs.
  • Establishes a federal cannabis regulatory structure: an FDA Center for Cannabis Products, product standards, labeling rules, and a permit system for producers and distributors under an amended Federal Alcohol Administration Act.
  • Provides restorative justice and economic programs: automatic or court-ordered expungement, community reinvestment grants, SBA loan programs and equitable licensing grants for people and places affected by the War on Drugs.
  • Includes public-safety measures: impaired-driving research, state grant program to prevent cannabis-impaired driving, and tracking and tracing rules to reduce diversion and smuggling.

What it means for you#

  • People with past federal cannabis convictions

    • Many federal cannabis convictions and related arrests would be vacated or expunged. People not serving other sentences may be released or have records sealed. Courts will conduct reviews and may reopen sentencing in some cases.

  • Immigrants

    • Cannabis-related arrests, admissions, or convictions would not be counted against a person for immigration benefits or deportation under federal immigration law.

  • Patients and veterans

    • The Department of Veterans Affairs must run clinical trials on cannabis for chronic pain and PTSD. VA and Indian Health Service providers may give recommendations about participation in state or tribal cannabis programs.

  • Consumers

    • Federal rules would require labels stating THC content and other product information. Sale to anyone under 21 would be prohibited at the federal level. Certain flavors in electronic cannabis delivery systems would be banned.

  • Retailers and transporters

    • Producers, importers, and wholesalers must get federal permits to operate in interstate commerce. States remain able to set their own rules for sale and possession once products enter the state, but the bill says states may not prohibit transportation through their territory.

  • Businesses and small lenders

    • Small Business Administration programs, Small Business Development Centers, and other assistance programs must be available to lawful cannabis businesses and related service providers. New SBA pilot loan programs and grants target owners adversely affected by past enforcement.

  • Banks and financial institutions

    • Financial institutions that serve legal cannabis businesses would get updated FinCEN guidance and uniform examination procedures. The bill directs changes to suspicious-activity reporting rules to reduce uncertainty.

  • State and local governments

    • States keep authority to regulate sale, taxation, and stricter safety or advertising standards. The bill creates federal grants that states can apply for (for impaired-driving prevention, community reinvestment, housing, etc.).

  • Workers in the cannabis industry

    • OSHA and NIOSH guidance and training funding would be provided. Permit holders must comply with labor and workplace-safety laws; violations can affect federal permits.

Expenses#

Estimated public cost: The bill authorizes many multi-year appropriations but does not present an overall net cost estimate in the text.

Major appropriations and funding items in the bill:

  • NIH and HHS cannabis research and infrastructure: multiple items (for example, $200 million per year for biomedical research; $200 million per year for cannabis research infrastructure grants; $275 million per year to increase research-grade product availability).
  • FDA and public health: $425 million per year (FY2026–2030) to implement FDA responsibilities for cannabis.
  • Cannabis-impaired driving and DOT research: $30 million per year (FY2026–2030) plus a $45 million per year state grant program.
  • Community reinvestment and restorative justice:
    • $1.65 billion (one-time appropriation for FY2026) for community reinvestment grants.
    • $550 million (one-time appropriation for FY2026) for equitable licensing grants.
    • $17 million (one-time appropriation for FY2026) for the Cannabis Restorative Opportunity Program.
  • SBA pilot lending and support: specified appropriations (e.g., $90 million and $41 million for FY2026).
  • Treasury / Tax & Trade Bureau and ATF-type enforcement: $100 million per year (FY2026–2030) for the Alcohol, Tobacco, and Cannabis Tax and Trade Bureau.
  • Community development and housing grants: $300 million per year (FY2026–2030) for HUD grants; $200 million per year (FY2026–2030) to the CDFI Fund; $200 million per year (FY2026–2030) to the Emergency Capital Investment Fund.
  • Other smaller grants: youth prevention campaigns, FDA transitions, VA clinical trials, workplace grants, law enforcement training—all with specified amounts in the bill.

Revenue side:

  • The bill imposes a federal tax on cannabis products. It phases in percentages (10% for first two years, then 15%, 20%, 25%) and then sets later taxes linked to prevailing prices and THC grams. Net revenues are credited to an “Opportunity Trust Fund” to support programs above.

Unclear items:

  • The bill sets many appropriations and a tax, but it does not include a single overall fiscal estimate or projection of net revenue versus cost in the text. No official score or total fiscal impact is included in the bill text.
    • No publicly available information in the bill text about the net budgetary effect or long-term revenue estimates.

Proponents' View#

The bill’s findings and provisions indicate goals and reasons someone might support it:

  • The bill appears intended to end federal criminal penalties for cannabis use and to align federal law with state legalization changes.
  • It aims to repair damage from decades of cannabis prohibition by funding community reinvestment, expunging records, and helping people who were disproportionately harmed enter the legal market.
  • It could be seen as improving public health and safety by requiring product standards, labeling, research, and impaired-driving studies and prevention programs.
  • The bill appears intended to remove banking and capital barriers for legal cannabis businesses by directing federal agencies to allow financial and small-business programs to serve them.
  • It could be seen as creating clearer, nationwide regulatory and tax structures so products can be tracked, taxed, and regulated for consumer safety.

Opponents' View#

The bill text also raises several concerns or questions someone might reasonably raise:

  • One concern is the large administrative and enforcement costs the federal government would incur. The bill creates multiple new offices, programs, and appropriations without a single net-cost estimate in the text.
  • One concern is the complexity of implementing retroactive changes to thousands of pending and past federal cases. Practical details about timing, court workload, and how states and federal agencies coordinate are not fully described.
  • One concern is potential regulatory and compliance burden on small businesses: producers must meet federal permit, bonding, tracking, labeling, and tax rules that could be costly even as SBA programs try to help.
  • One concern is that the bill changes transportation rules (prohibiting states or tribes from banning transit of cannabis through their territory). This could create legal tensions between state policies and interstate commerce that the bill does not fully resolve.
  • One concern is financial-sector uncertainty: the bill updates FinCEN guidance and examination procedures, but banks may remain cautious about compliance risk until detailed guidance and practice are established.
  • It is unclear how the federal rules will interact with international treaty obligations or with State laws in all practical details. The bill preserves many state powers but also asserts federal rules that may create friction; the text does not settle every intergovernmental issue.